STAT

Trump administration quietly unveils new round of Medicare-negotiated drug prices

The New York Times

Drugs Prices Medicare.Html

Metaculus

Universal Healthcare in the US by 2040

The Washington Examiner

Medicare drug price negotiation: Innovation chilled at what cost

USA Today

Medicare announces lower prices for 15 drugs including Ozempic, Wegovy

Breitbart

Trump administration says lower prices for 15 Medicare drugs will save taxpayers billions

FOX 8

The Hill

Trump administration unveils Medicare negotiated price cuts for 15 drugs, including Ozempic

The Epoch Times

Medicare Slashes Prices for 15 Prescription Drugs

Medicare announces price cuts for 15 prescription drugs, including Ozempic

Fierce Pharma

Medicare unveils price reductions for 15 drugs, including Novo's semaglutide

Centers for Medicare & Medicaid Services (CMS)

CMS Delivers Savings for Seniors on 15 Major Drugs for Cancer and Chronic Disease

Fox 59

Trump admin says drug price negotiations will save Medicare roughly $12 billion

KFF Health News

Medicare To Lower Prices On 15 More Prescription Drugs, Including Ozempic

The Washington Times

USC Schaeffer

Analysis Finds Meaningful Impact on Pharmaceutical Innovation From Reduced Revenues

The Trump administration announced negotiated prices for 15 prescription drugs under Medicare's drug price negotiation program, with the new prices taking effect in 2027 and expected to save Medicare $12 billion annually compared to previous spending levels.

The Trump administration announced negotiated prices for 15 prescription drugs under Medicare's drug price negotiation program, with the new prices taking effect in 2027 and expected to save Medicare $12 billion annually compared to previous spending levels.

The Medicare drug price negotiation program was established through the Inflation Reduction Act, which President Biden signed into law in 2022 without any Republican votes, empowering the health secretary to negotiate on behalf of Medicare.

The Medicare drug price negotiation program was established through the Inflation Reduction Act, which President Biden signed into law in 2022 without any Republican votes, empowering the health secretary to negotiate on behalf of Medicare.

The 15 drugs selected for negotiation include widely used medications such as Ozempic and Wegovy for diabetes and weight loss, cancer treatments, inhalers and depression medications, accounting for $42.5 billion in Medicare Part D spending in 2024.

The 15 drugs selected for negotiation include widely used medications such as Ozempic and Wegovy for diabetes and weight loss, cancer treatments, inhalers and depression medications, accounting for $42.5 billion in Medicare Part D spending in 2024.

CMS Administrator Mehmet Oz stated the Trump administration achieved substantially better outcomes than the previous year's negotiations, while Senator Ron Wyden credited Democratic efforts for creating the program that enabled these price reductions.

CMS Administrator Mehmet Oz stated the Trump administration achieved substantially better outcomes than the previous year's negotiations, while Senator Ron Wyden credited Democratic efforts for creating the program that enabled these price reductions.

The negotiated price reductions range from 38 percent to 85 percent off list prices, with Ozempic priced at $277 monthly and Wegovy at $386 monthly, though Medicare already receives confidential discounts that make true savings difficult to determine.

The negotiated price reductions range from 38 percent to 85 percent off list prices, with Ozempic priced at $277 monthly and Wegovy at $386 monthly, though Medicare already receives confidential discounts that make true savings difficult to determine.

Pharmaceutical companies opposed the negotiation program and challenged it in court unsuccessfully, with industry representatives arguing that government price setting threatens future medical innovation by reducing funds available for research.

Pharmaceutical companies opposed the negotiation program and challenged it in court unsuccessfully, with industry representatives arguing that government price setting threatens future medical innovation by reducing funds available for research.

STAT #

The New York Times #

Metaculus #

The Washington Examiner #

USA Today #

Breitbart #

FOX 8 #

The Hill #

The Epoch Times #

NBC #

Fierce Pharma #

Centers for Medicare & Medicaid Services (CMS) #

Fox 59 #

CNN #

KFF Health News #

The Washington Times #

USC Schaeffer #

Trump Admin Announces Medicare Drug Price Cuts Saving $12B

Health

Medicare

Pharmaceuticals

United States of America

Trump Admin Announces Medicare Drug Price Cuts Saving $12B

Trump Admin Announces Medicare Drug Price Cuts Saving $12B

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters